Seoul, South Korea

Myung Hyun Jang

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Myung Hyun Jang: Revolutionizing Biopharmaceutical Innovations

Introduction

Myung Hyun Jang is a prominent inventor based in Seoul, South Korea, renowned for his contributions to the field of biopharmaceuticals. With an impressive portfolio of 15 patents, he has significantly advanced the development of therapeutic polypeptides, focusing on improving their stability and efficacy for medical applications.

Latest Patents

Among his latest innovations, Jang has developed a method for preparing a physiologically active polypeptide complex. This innovative technique involves linking physiologically active polypeptides with non-peptide polymers through a covalent bond using organic solvents. The resulting conjugate not only exhibits improved in vivo duration and stability but is also produced at a lower cost. This extended half-life enhances the therapeutic potential of the polypeptide.

In addition, Jang has disclosed another groundbreaking process for preparing physiologically active polypeptide complexes. This method covalently bonds a physiologically active polypeptide to an immunoglobulin constant region via a non-peptidyl linker, utilizing a reducing agent to overcome typical challenges related to production yield and polypeptide modification. The resulting high-purity complexes can be efficiently used to develop long-acting formulations, enhancing drug compliance.

Career Highlights

Myung Hyun Jang has had a distinguished career, working with reputable companies such as Hanmi Science Co., Ltd. and Hanmi Pharm. Co., Ltd. His innovative research and dedication to developing cost-effective solutions have made him a leader in his field, driving significant advancements in biopharmaceutical technologies.

Collaborations

Throughout his career, Jang has collaborated with esteemed colleagues, including Se Chang Kwon and Sung Youb Jung. These collaborations have allowed for the exchange of ideas and further stimulated innovation in the development of therapeutic agents.

Conclusion

Myung Hyun Jang's contributions to biopharmaceutical innovation are noteworthy, with a focus on enhancing the efficacy and stability of physiologically active polypeptides. His advancements are set to play a crucial role in the future of drug development, underscoring the importance of continuous innovation in the healthcare sector. Through his patents and collaborations, Jang exemplifies the spirit of invention, making a lasting impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…